Parameter
| Biomarker | LDH | Full name | Lactate Dehydrogenase | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis assessment, efficacy monitoring |
| Disease | TGCT | Disease Subtypes | / | ||
| Organ | Testis | Test Sample / Technology Platform | Serum (chemiluminescence immunoassay, electrochemiluminescence immunoassay) | ||
| Pathobiological Mechanisms | The ubiquitous cellular enzymes released into the bloodstream during tumor cell necrosis or rapid proliferation serve as indirect indicators of tumor burden. | ||||
| Clinical Availability Status | Routine clinical application (guideline Standard) | ||||
| Notes and Dynamics | It exhibits low sensitivity and specificity, and may also be elevated in various non-neoplastic conditions (e.g., hemolysis, myocardial infarction). It serves as a critical indicator in the IGCCCG prognostic staging system. | ||||